250
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Prevalence, Determinants And Associated Risk Of Potentially Inappropriate Prescribing For Older Adults In Qatar: A National Retrospective Study

, ORCID Icon, ORCID Icon &
Pages 1889-1899 | Published online: 01 Nov 2019

References

  • United Nations. World population prospects: the 2019 revision. Available from:http://www.un.org/en/sections/issues-depth/ageingAccessed 520, 2019.
  • Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):695. doi:10.1186/s12877-017-0621-2
  • Van Farrell B, Shamji S, Monahan A, French Merkley V. Reducing polypharmacy in the elderly. Can Pharm J. 2013;146(5):243–244. doi:10.1177/1715163513499530
  • Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract. 2011;61(583):83–84. doi:10.3399/bjgp11X55614621276330
  • Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–724. doi:10.1001/jama.294.6.71616091574
  • Masoodi NA. Polypharmacy: to err is human, to correct divine. Br J Med Pract. 2008;1(1):6–9. Available from: http://www.bjmp.org/files/sept2008/bjmp0908namasoodi.pdf.
  • Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648–1654. doi:10.1001/archinternmed.2010.35520937924
  • Opondo D, Eslami S, Visscher S, et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One. 2012;7(8):e43617. doi:10.1371/journal.pone.004361722928004
  • Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S. Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals. J Postgrad Med. 2010;56(3):186–191. doi:10.4103/0022-3859.6864220739763
  • Chang C-M, Liu P-Y-Y, Yang Y-HK, Yang Y-C, Wu C-F, Lu F-H. Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy. 2005;25(6):831–838. doi:10.1592/phco.2005.25.6.83115927902
  • Anderson G, Horvath J. Chronic Conditions: Making the Case for Ongoing Care. 1st ed. Baltimore, MD: Johns Hopkins University; 2002.
  • Grimley Evans J, Franklin Williams T, Lynn Beattie B, Michael J-P, Wilcock GK. Oxford Textbook of Geriatric Medicine. 2nd ed. Oxford: Oxford University Press; 2003.
  • Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van Den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54(7):661–674. doi:10.1016/s0895-4356(00)00363-211438406
  • Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52(8):1349–1354. doi:10.1111/j.1532-5415.2004.52367.x15271125
  • Barber N. What constitutes good prescribing? BMJ. 1995;310(6984):923–925. doi:10.1136/bmj.310.6984.9237719188
  • Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543–552. doi:10.1111/j.1365-2125.2010.03628.x20573091
  • Reich O, Rosemann T, Rapold R, Blozik E, Senn O. Potentially inappropriate medication use in older patients in swiss managed care plans: prevalence, determinants, and association with hospitalization. PLoS One. 2014;9(8):e105425. doi:10.1371/journal.pone.010542525136981
  • Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–372. doi:10.1111/jcpt.1205923550814
  • Kaufmann CP, Tremp R, Hersberger KE, Lampert ML. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70(1):1–11. doi:10.1007/s00228-013-1575-824019054
  • American Geriatrics Society, New York, New York. Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.1576730693946
  • Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817–832. doi:10.2165/00002512-200320110-0000312964888
  • United Nations. World population ageing: highlights. Available from: https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2015_Highlights.pdf Accessed 314, 2019.
  • National Kidney Foundation. How to classify CKD. Available from: www.kidney.org/professionals/explore-your-knowledge/how-to-classify-ckd Accessed 515, 2019.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604. doi:10.7326/0003-4819-150-9-200905050-0000619414839
  • Nuttall FQ. Body mass index. Nutr Today. 2015;50(3):117–128. doi:10.1097/NT.000000000000009227340299
  • Buuren S, MICE: G-OK. Multivariate imputation by chained equations in R. J Stat Soft. 2011;45(3). doi:10.18637/jss.v045.i03
  • Rawle MJ, Cooper R, Kuh D, Richards M. Associations between polypharmacy and cognitive and physical capability: a british birth cohort study. J Am Geriatr Soc. 2018;66(5):916–923. doi:10.1111/jgs.1531729574684
  • Lu W-H, Wen Y-W, Chen L-K, Hsiao F-Y. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ. 2015;187(4):E130–E137. doi:10.1503/cmaj.14121925646290
  • Wimmer BC, Bell JS, Fastbom J, Wiese MD, Johnell K. Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people. Ann Pharmacother. 2016;50(2):89–95. doi:10.1177/106002801562107126681444
  • Tommelein E, Mehuys E, van Tongelen I, et al. Community pharmacists’ evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP3S tool. J Public Health (Oxf). 2017;39(3):583–592. doi:10.1093/pubmed/fdw10827698269
  • Montastruc F, Gardette V, Cantet C, et al. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs. Eur J Clin Pharmacol. 2013;69(8):1589–1597. doi:10.1007/s00228-013-1506-823588564
  • Filomena Paci J, Garcia Alfaro M, Reedonodo Alonso FJ, Fernández SanMartín MI; Grupo Polimedicación Litoral. Inappropriate prescribing in polymedicated patients over 64 years old in primary care. Aten Primaria. 2015;47(1):38–47. doi:10.1016/j.aprim.2014.03.01325113921
  • Bregnhoj L, Thirstrup S, Kristensen MB, Bjerrum L, Sonne J. Prevalence of inappropriate prescribing in primary care. Pharm World Sci. 2007;29(3):109–115. doi:10.1007/s11096-007-9108-017353970
  • Koper D, Kamenski G, Flamm M, Böhmdorfer B, Sönnichsen A. Frequency of medication errors in primary care patients with polypharmacy. Fam Pract. 2013;30(3):313–319. doi:10.1093/fampra/cms07023132894
  • KAJ AK, Ahmed Isa H, Veeramuthu S, Sequeira RP. Potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension in a primary care setting in Bahrain. Med Princ Pract. 2018;27(3):241–249. doi:10.1159/00048805529495011
  • Alhmoud E, Khalifa S, Bahi AA. Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm. 2015;37(5):815–821. doi:10.1007/s11096-015-0125-025986290